4/17
12:19 pm
cgon
CG Oncology (CGON) had its price target raised by JPMorgan Chase & Co. from $65.00 to $91.00. They now have an "overweight" rating on the stock.
Medium
Report
CG Oncology (CGON) had its price target raised by JPMorgan Chase & Co. from $65.00 to $91.00. They now have an "overweight" rating on the stock.
4/11
01:00 am
cgon
Low
Report
4/7
08:02 am
cgon
CG Oncology (CGON) had its price target raised by HC Wainwright from $80.00 to $100.00. They now have a "buy" rating on the stock.
Medium
Report
CG Oncology (CGON) had its price target raised by HC Wainwright from $80.00 to $100.00. They now have a "buy" rating on the stock.
4/5
04:57 am
cgon
CG Oncology: Passing A Red Line For What I Would Call A Reasonable Valuation (Rating Downgrade) [Seeking Alpha]
Low
Report
CG Oncology: Passing A Red Line For What I Would Call A Reasonable Valuation (Rating Downgrade) [Seeking Alpha]
3/28
01:05 am
cgon
Low
Report
3/21
06:34 pm
cgon
This Biotech Stock Up 135% Just Faced a $44 Million Trim. Here's What Investors Should Know [Yahoo! Finance]
Low
Report
This Biotech Stock Up 135% Just Faced a $44 Million Trim. Here's What Investors Should Know [Yahoo! Finance]
3/14
09:51 pm
cgon
Is CG Oncology (CGON) Pricing Reflect Its Recent 131% Surge And Cancer Breakthrough Hopes [Yahoo! Finance]
Low
Report
Is CG Oncology (CGON) Pricing Reflect Its Recent 131% Surge And Cancer Breakthrough Hopes [Yahoo! Finance]
3/8
03:15 am
cgon
CG Oncology Conference: Credo Posts 75.5% CR in BOND-003, BLA Filing Targeted for 2026 [Yahoo! Finance]
Low
Report
CG Oncology Conference: Credo Posts 75.5% CR in BOND-003, BLA Filing Targeted for 2026 [Yahoo! Finance]
11/14/2025
08:00 am
cgon
cg oncology, inc. - common stock
IN-LINE
Report
7.8%
cg oncology, inc. - common stock
5/13/2025
08:00 am
cgon
cg oncology, inc. - common stock
MISS
Report
0.0%
cg oncology, inc. - common stock
4/17
04:34 pm
cgon
Form 144 CG Oncology, Inc. Filed by: Mulay James
Low
Report
Form 144 CG Oncology, Inc. Filed by: Mulay James
4/16
04:15 pm
cgon
Form 4 CG Oncology, Inc. For: Apr 15 Filed by: DETORE JAMES M.
High
Report
Form 4 CG Oncology, Inc. For: Apr 15 Filed by: DETORE JAMES M.
4/16
04:15 pm
cgon
Form 4 CG Oncology, Inc. For: Apr 15 Filed by: Bellete Ambaw
High
Report
Form 4 CG Oncology, Inc. For: Apr 15 Filed by: Bellete Ambaw
4/16
04:15 pm
cgon
Form 4 CG Oncology, Inc. For: Apr 15 Filed by: Kuan Arthur
High
Report
Form 4 CG Oncology, Inc. For: Apr 15 Filed by: Kuan Arthur
4/16
04:15 pm
cgon
Form 4 CG Oncology, Inc. For: Apr 15 Filed by: Patterson Joshua F.
High
Report
Form 4 CG Oncology, Inc. For: Apr 15 Filed by: Patterson Joshua F.
4/16
04:15 pm
cgon
Form 4 CG Oncology, Inc. For: Apr 15 Filed by: Kasturi Vijay
High
Report
Form 4 CG Oncology, Inc. For: Apr 15 Filed by: Kasturi Vijay
4/13
08:30 am
cgon
Form 8-K CG Oncology, Inc. For: Apr 13
Low
Report
Form 8-K CG Oncology, Inc. For: Apr 13
3/26
05:13 pm
cgon
Form SCHEDULE 13G/A CG Oncology, Inc. Filed by: VANGUARD GROUP INC
Medium
Report
Form SCHEDULE 13G/A CG Oncology, Inc. Filed by: VANGUARD GROUP INC
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register